Overview

Gender

female

Dr. Dawn Bell is a global, strategic, biopharmaceutical executive (NYSE: NVS), Board
Director, GM, and CEO with demonstrated success as an operator and advisor across the drug development value chain. She has 20+ years of proven success starting and scaling life-science businesses from academic spinouts to Top 5 Pharma. Provides rapidly growing companies insights on corporate strategy, value creation, business development, team building, and culture. Board director and advisor for privately held
life-science companies, research institutes, CEOs, founders, and innovation accelerators
in the US and Europe across various therapeutic areas.